Effectiveness and Safety of Qiaoqi Formula （翘芪组方） for Mild Influenza： A 36-case Randomized Controlled Trial
10.13288/j.11-2166/r.2024.07.009
- VernacularTitle:翘芪组方治疗流行性感冒轻症患者36例有效性与安全性的随机对照试验
- Author:
Desong KONG
1
;
Feng ZHAO
1
;
Yanliang ZHANG
1
;
Yu ZHANG
2
;
Jinghua ZHANG
1
;
Ye YANG
3
;
Guoxue ZHU
1
;
Leilei GONG
4
;
Xiaosong GU
4
;
Heming YU
1
Author Information
1. Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine， Nanjing， 210022
2. Affiliated Hospital of Nanjing University of Chinese Medicine
3. Nanjing University of Chinese Medicine
4. Nantong University
- Publication Type:Journal Article
- Keywords:
influenza;
Qiaoqi Formula （翘芪组方）;
Lianhua Qingwen Capsule （连花清瘟胶囊）;
fever reduction;
randomized controlled trial
- From:Journal of Traditional Chinese Medicine
2024;65(7):710-715
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the effectiveness and safety of Qiaoqi Formula （翘芪组方） for mild influenza. MethodsA randomized controlled study was designed， recruiting 74 patients with mild influenza， who were randomly divided into trial group and control group. The trial group took Qiaoqi Formula orally， 40ml each time， twice a day； the control group took Lianhua Qingwen Capsules （连花清瘟胶囊） orally， 1.4 g each time， three times a day. Both groups were treated for 3 consecutive days and follow-up for 4 consecutive days after treatment. The time for fever reduction including onset of fever reduction， complete fever reduction time， fever reduction rates at 24， 48 and 72 hours， improvement of influenza symptoms， total traditional Chinese medicine （TCM） symptom score， and safety indicators in two groups after treatment were recorded. ResultsSixty-five patients were ultimately included， including 36 in the trial group and 29 in the control group. Onset time of fever reduction in the trial group was （15.49±23.47） h， the complete fever reduction time （21.37±30.06）h， and the 24 h， 48 h， 72 h， fever reduction rate was 77.14%， 88.57%， 91.42% respectively. The above indicators of the control group showed as （17.58±20.38）h， （24.30±21.87）h， 61.29%， 90.32%， 96.77% respectively， with no statistically significant differences （P＞0.05）. On the 7th day after treatment， the total score of TCM syndromes in trial group and control group decreased compared to those before treatment （P＜0.05）. There was no statistically significant difference in the cure rate， significant effective rate， effective rate， and total effective rate of TCM syndromes between groups （P＞0.05）. On the 4th day， the lymphocyte ratio of patients in the control group was higher than before treatment， while alanine aminotransferase （ALT）， aspartate aminotransferase （AST）， urea， and creatinine of both groups before and after treatment were within the normal range. The main adverse reactions in both groups were mild headache and dizziness， and no serious adverse reactions observed. ConclusionThe therapeutic effect of Qiaoqi Formula in treating mild influenza is equivalent to Lianhua Qingwen Capsules， which can shorten the fever reduction time， improve clinical symptoms， and no adverse events observed during the study.
